Learn More
A multicenter, double-blind, placebo-controlled trial was carried out to evaluate the intra-lesional infiltration of recombinant epidermal growth factor (EGF) in Wagner's grade 3 or 4 diabetic foot(More)
Previous studies have shown that an epidermal growth factor-based formulation (Heberprot-P) can enhance granulation of high-grade diabetic foot ulcers (DFU). The aim of this study was to explore the(More)
1Tissue Repair and Cyto-Protection Research Group, Biomedical Research Direction. Center for Genetic Engineering and Biotechnology, PO Box 6162, Cuabanacan, Playa 10600. Havana City, Cuba 2Cancer(More)